Progress in cardiovascular diseases over the years reflects advancements in medical science, technology, and healthcare delivery, leading to improved prevention, diagnosis, and treatment of various cardiovascular conditions. Innovations in imaging modalities, such as cardiac MRI and CT angiography, allow for more accurate and detailed visualization of the heart and blood vessels. Breakthroughs in interventional cardiology, including the development of drug-eluting stents and minimally invasive procedures like transcatheter valve replacements, have revolutionized the treatment of coronary artery disease and structural heart disorders. Progress in pharmacotherapy has introduced novel medications targeting specific pathways to manage hypertension, dyslipidemia, and heart failure more effectively. Moreover, the integration of data-driven approaches, artificial intelligence, and personalized medicine holds promise for further advancements in tailoring cardiovascular care to individual patient needs. These collective efforts contribute to reducing mortality, improving quality of life, and shaping a more optimistic outlook for individuals facing cardiovascular diseases.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation